These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2992811)

  • 1. Killer cells of feline leukemia virus- and feline sarcoma virus-infected transformed cells: the role of NK, ADCC, and in vitro generated cytotoxic cells.
    Kooistra LH; Splitter GA
    Cell Immunol; 1985 Sep; 94(2):466-79. PubMed ID: 2992811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feline cytotoxic immune mechanisms against virus-associated leukemia and fibrosarcoma.
    McCarty JM; Grant CK
    Cell Immunol; 1983 Oct; 81(1):157-68. PubMed ID: 6311439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
    Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
    J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus.
    Mathes LE; Olsen RG; Hebebrand LC; Hoover EA; Schaller JP; Adams PW; Nichols WS
    Cancer Res; 1979 Mar; 39(3):950-5. PubMed ID: 218725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of a cell-mediated cytotoxic response to FeLV-induced T cell lymphomas in the cat.
    Tompkins MB; Tompkins WA
    J Immunol; 1985 Oct; 135(4):2817-23. PubMed ID: 2993416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immune response in the blood of cats is restricted to autochthonous feline sarcoma virus-transformed cells.
    McCarty JM; Grant CK
    Int J Cancer; 1983 May; 31(5):627-31. PubMed ID: 6852979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feline oncornavirus-associated cell membrane antigen: a viral and not a cellularly coded transformation-specific antigen of cat lymphomas.
    Vedbrat SS; Rasheed S; Lutz H; Gonda MA; Ruscetti S; Gardner MB; Prensky W
    Virology; 1983 Jan; 124(2):445-61. PubMed ID: 6186079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feline oncornavirus-associated cell membrane antigen: evidence for an immunologically crossreactive feline sarcoma virus-coded protein.
    Stephenson JR; Khan AS; Sliski AH; Essex M
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5608-12. PubMed ID: 202959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
    Rojko JL; Hoover EA; Finn BL; Olsen RG
    J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feline leukemia virus-and feline sarcoma virus-related polypeptides released by virus producer and nonproducer cells.
    Ganguly K; Essex M
    Cancer Invest; 1985; 3(6):523-34. PubMed ID: 3002564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between feline leukemia virus antigen expression and viral infectivity in blood, bone marrow, and saliva of cats.
    Hoover EA; Olsen RG; Mathes LE; Schaller JP
    Cancer Res; 1977 Oct; 37(10):3707-10. PubMed ID: 198120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia specific antigens: FOCMA and immune surveillance.
    Essex M; Grant CK; Cotter SM; Sliski AH; Hardy WD
    Haematol Blood Transfus; 1979; 23():453-86. PubMed ID: 232469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a feline sarcoma virus-coded antigen (FOCMA-S) by radioimmunoassay.
    Sherr CJ; Todaro GJ; Sliski A; Essex M
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4489-93. PubMed ID: 212755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection with feline leukemia virus associated with induction of humoral response to a normal cell protein.
    Chen AP; Essex ME
    Cancer Invest; 1984; 2(2):81-90. PubMed ID: 6329486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal analysis of feline leukemia virus-specific cytotoxic T lymphocytes: correlation with recovery from infection.
    Flynn JN; Dunham SP; Watson V; Jarrett O
    J Virol; 2002 Mar; 76(5):2306-15. PubMed ID: 11836409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The feline oncornavirus-associated cell membrane antigen (FOCMA) is related to, but distinguishable from, FeLV-C gp70.
    Snyder HW; Singhal MC; Zuckerman EE; Jones FR; Hardy WD
    Virology; 1983 Dec; 131(2):315-27. PubMed ID: 6318434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of immunity to Snyder-Theilen fibrosarcoma virus induced tumors in cats.
    Johnson L; Pedersen NC; Theilen GH
    Vet Immunol Immunopathol; 1985 Jul; 9(3):283-300. PubMed ID: 2994282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feline oncornavirus-associated cell membrane antigen. VI. Cytotoxic antibody in cats exposed to feline leukemia virus.
    Mathes LE; Yohn DS; Hoover EA; Essex M; Schaller JP; Olsen RG
    J Natl Cancer Inst; 1976 Jun; 56(6):1197-200. PubMed ID: 186623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abrogation of resistance to feline oncornavirus disease by immunization with killed feline leukemia virus.
    Olsen RG; Hoover EA; Schaller JP; Mathes LE; Wolff LH
    Cancer Res; 1977 Jul; 37(7 Pt 1):2082-5. PubMed ID: 67886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to leukemia virus and tumor-associated antigens in cats.
    Essex M; Sliski A; Hardy WD; Cotter SM
    Cancer Res; 1976 Feb; 36(2 pt 2):640-5. PubMed ID: 56224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.